Effect of Neural Mobilization in Upper Cross Syndrome
Launched by CAIRO UNIVERSITY · Jun 4, 2025
Trial Information
Current as of November 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a treatment called Neural Mobilization on people with Upper Cross Syndrome, a condition that often leads to neck and shoulder pain due to poor posture. The main goal is to find out if this treatment can help improve pain levels and posture in affected individuals. The trial is not yet recruiting participants, but when it does, it will include men and women aged 20 to 50 years who have specific signs of Upper Cross Syndrome, such as a forward head position and rounded shoulders, along with moderate pain.
To be eligible for the study, participants must have a certain body weight and pain levels that can be measured on a scale from 0 to 10. However, people with a history of neck injuries, certain medical conditions, or who are pregnant will not be able to participate. If you qualify and decide to join, you can expect to receive the Neural Mobilization treatment and be monitored for any changes in your symptoms and posture. This trial aims to provide insights that could lead to better management of Upper Cross Syndrome for many individuals.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ranged from 20 to 50 years.
- • Body Mass Index ≤30 kg/m².
- • All participants have a forward head, craniovertebral angle \< 50°.
- • All participants have round back (kyphosis angle ≥ 42°).
- • All participants have rounded shoulders of ≥ 52°.
- • The subjects were chosen from both genders based on an assessment of upper cross syndrome by photogrammetric analysis.
- • All participants have pain intensity level measured by visual analogue scale (4-8).
- • All participants tested positive for upper limb tension test of median nerve.
- Exclusion Criteria:
- • History of trauma or surgery in the cervical region.
- • Bone fractures or acute soft tissue injuries.
- • Osteoporosis.
- • Pregnant women.
- • Cancer.
- • Neurological conditions affecting cervical and thoracic spine.
- • Connective tissue disease: This includes diseases such as osteomyelitis, lupus, and scleroderma.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Giza, Egypt
Patients applied
Trial Officials
Abeer Abdelrahman, PhD
Study Chair
Professor, Cairo university
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported